Chemoprevention of Prostate Cancer with Finasteride (Proscar®), Phase III, Intergroup (PCPT)
Treatment
Eligibility Criteria Expand/Collapse
Eligibility for enrollment: male, >= 55 years, PS=0, DRE within normal limits, no prior prostate ca, no prior finasteride or anabolic steroids, no prior systemic therapy for cancer, must not be in urinary retention or have urinary obstructive symptoms or severe prostatism.
CANCER CONTROL CREDIT: 1.0
Publication Information Expand/Collapse
2024
Long-term side effects and complications after prostate cancer treatment
J Unger;C Till;C Tangen;D Hershman;P Goodman;M Leblanc;W Barlow;R Vaidya;L Minasian;H Parnes;IM Thompson JAMA Oncology Nov 7:e244397. doi: 10.1001/jamaoncol.2024.4397. Online ahead of print
PMid: PMID39509091 | PMC number: PMC11544550
M Stern;J Sanchez Mendez;A Kim;M Obon-Santacana;F Moratalla-Navarro;V Martin;V Moreno;Y Lin;S Bien;C Qu;Y Su;E White;T Harrison;J Huyghe;C Tangen;P Newcomb;A Phipps;C Thomas;E Kawaguchi;J Lewinger;J Morrison;D Conti;J Wang;D Thomas;E Platz;K Visvanathan;T Keku;C Newton;C Um;A Kundaje;A Shcherbina;N Murphy;M Gunter;N Dimou;N Papadimitriou;S Bezieau;F van Duijnhoven;S Mannisto;G Rennert;A Wolk;M Hoffmeister;H Brenner;J Chang-Claude;Y Tian;L LeMarchand;M Cotterchio;K Tsilidis;D Bishop;Y Melaku;B Lynch;D Buchanan;C Ulrich;J Ose;A Peoples;A Pellatt;M Devall;P Campbell;D Albanes;S Weinstein;S Berndt;S Gruber;E Ruiz-Narvaez;M Song;A Joshi;D Drew;J Petrick;A Chan;M Giannakis;U Peters;L Hsu;W Gauderman CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Mar 1;33(3):400-410
PMid: PMID38112776 | PMC number: PMC11343583
Z Ni;P Kundu;D McKean;W Wheeler;D Albanes;G Andreotti;S Antwi;A Arslan;W Bamlet;L Freeman;S Berndt;P Bracci;P Brennan;J Buring;S Chanock;S Gallinger;JM Gaziano;G Giles;E Giovannucci;M Goggins;P Goodman;C Haiman;M Hassan;E Holly;R Hung;V Katzke;C Kooperberg;P Kraft;L Le Marchand;D Li;M McCullough;R Milne;S Moore;R Neale;A Oberg;A Patel;U Peters;K Rabe;H Risch;X Shu;K Byrne;K Visvanathan;J Wactawski-Wende;E White;B Wolpin;H Yu;A Zeleniuch-Jacquotte;W Zheng;J Zhong;L Amundadottir;R Stolzenberg-Solomon;A Klein Cancer Epidemiology, Biomarkers & Prevention Jun 13. doi: 10.1158/1055-9965.EPI-24-0096. Online ahead of print
PMid: PMID38869494
2023
Genetically Adjusted PSA Levels for Prostate Cancer Screening
L Kachuri;T Hoffmann;Y Jiang;S Berndt;J Shelley;K Schaffer;M Machiela;N Freedman;W Huang;S Li;R Easterlin;P Goodman;C Till;I Thompson;H Lilja;S Van Den Eeden;S Chanock;C Haiman;D Conti;R Klein;J Mosley;R Graff;J Witte Nature Medicine Jun;29(6):1412-1423
PMid: PMID37264206 | PMC number: PMC10287565
B Darst;J Shen;R Madduri;A Rodriguez;Y Xiao;X Sheng;E Saunders;T Dadaev;M Brook;T Hoffmann;K Muir;P Wan;L LeMarchand;L Wilkens;Y Wang;J Schleutker;R MacInnis;D Albanes;C Tangen;Z Kote-Jarai;S Watya;J Gaziano;A Justice;D Conti;C Haiman American Journal of Human Genetics Jul 6;110(7):1200-1206
PMid: PMID37292833 | PMC number: PMC10246022
F Chen;R Madduri;A Rodriguez;B Darst;A Chou;X Sheng;P Goodman;IM Thompson;EA Klein;J Witte;W Blot;JM Gaziano;A Justice;V Conti;C Haiman Eur Urol. Jul;84(1):13-21
PMid: PMID36872133 | PMC number: PMC10424812
2022
Serum Markers, Obesity and Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
C Chau;C Till;D Price;P Goodman;M Neuhouser;M Pollak;I Thompson;W Figg Endocrine-Related Cancer Jan 20;29(2):99-109. doi: 10.1530/ERC-21-0107
PMid: PMID34889205 | PMC number: PMC8776589
S Chadid;X Song;J Schenk;B Gurel;MS Lucia;I Thompson, Jr.;M Neuhouser;P Goodman;H Parnes;S Lippman;W Nelson;A De Marzo;E Platz Nutrition and Cancer 74(1):141-148
PMid: PMID33511883 | PMC number: PMC8319215
Circulating Inflammatory Cytokines and Risk of Five Cancers: a Mendelian Randomization Analysis
E Bouras;V Karhunen;J Huang;D Gill;P Brennan;M Gunter;P Haycock;M Johansson;T Key;S Lewis;R Martin;F Mengaux;N Murphy;E Platz;R Travis;T Truong;J Yarmolinsky;M-R Jarvelin;A Dehghan;K Tsilidis;Contributor C Tangen BMC Medicine Jan 11;20(1):3
PMid: PMID35012533 | PMC number: PMC8750876
A Ioannidou;E Watts;A Perez-Cornago;E Platz;I Mills;T Key;R Travis;K Tsilidis;V Zuber;Contributor C Tangen PLOS Medicine Jan 27;19(1):e1003859. doi: 10.1371/journal.pmed.1003859. eCollection 2022 Jan
PMid: PMID35085228 | PMC number: PMC8794090
E Watts;A Perez-Cornago;G Fensom;K Smith-Byrne;A Noor;C Andrews;M Gunter;M Holmes;R Martin;K Tsilidis;D Albanes;G Goodman;E Platz;J Schenk;Practical Consortium;N Allen;T Key;R Travis International Journal of Cancer Oct 1;151(7):1033-1046
PMid: PMID35579976 | PMC number: PMC7613289
A Rare Germline HOXB13 Variant Contributes to Risk of Prostate Cancer in Men of African Ancestry
B Darst;R Hughley;A Pfennig;U Hazra;C Fan;P Wan;X Sheng;E Klein;P Goodman;I Thompson;T Rebbeck;D Conti;C Haiman European Urology May;81(5):458-462
PMid: PMID35031163 | PMC number: PMC9018520
Z Gong;M Platek;C Till;P Goodman;C Tangen;EA Platz;M Neuhouser;IM Thompson;R Santella;C Ambrosone Frontiers in Oncology Jan 14;11:808715
PMid: PMID35096612 | PMC number: PMC8795906
M Huynh-Le;R Karunamuni;C Fan;L Asona;W Thompson;M Martinez;C Tangen;D Albanes;I Mills;O Andreassen;A Dale;T Seibert Prostate Cancer and Prostatic Diseases Apr;25(4):755-761
PMid: PMID35152271 | PMC number: PMC9372232
X Shu;Z Chen;J Long;X Guo;Y Yang;C Qu;Y Ahn;C Tangen;A Wu;U Peters;W Zheng Cancer Epidemiology Biomarkers & Prevention Mar 10;cebp.EPI-21-1008-E.2021. doi: 10.1158/1055-9965.EPI-21-1008. Online ahead of print
PMid: PMID35266989 | PMC number: PMC9354799
Intake Patterns of Specific Alcoholic Beverages by Prostate Cancer Status
H Lin;T Tseng;X Wang;Z Fang;A Zea;L Wang;J Pow-Sang;C Tangen;P Goodman;A Wolk;N Hakansson;M Kogevinas;J Llorca;H Brenner;B Schottker;J Castelao;M Gago-Dominguez;M Gamulin;D Lessel;F Claessens;S Joniau;Practical Consortium;J Park Cancers (Basel) Apr 14;14(8):1981
PMid: PMID35454886 | PMC number: PMC9024489
2021
D Conti;B Darst;EJ Saunders;X Sheng;A Chou;F Schumacher;D Albanes;C Tangen;P Goodman;IM Thompson;EA Klein;A Hsing;R Eeles;Z Kote-Jarai;C Haiman Nature Genetics, Jan;53(1):65-75
PMid: PMID33398198 | PMC number: PMC8148035
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
R Karunamuni;M Huynh-Le;C Fan;W Thompson;R Eeles;Z Kote-Jarai;C Tangen;P Goodman;IM Thompson;O Andreassen;A Dale;T Seibert International Journal of Cancer Jan 1;148(1):99-105. Epub 2020 Sep 24.Sep 15. doi: 10.1002/ijc.33282. Online ahead of print
PMid: PMID32930425 | PMC number: PMC8135907
Advancing traditional PSA kinetics in the detection of prostate cancer: A Machine Learning model
M Perera;L Smith;IM Thompson;J Breemer;N Pappa;M Patel;M Patel;P Swindle;E Smith European Urology Focus Dec 14;S2405-4569(21)00309-6. doi: 10.1016/j.euf.2021.11.009.
PMid: PMID34920976
A multilayered post-GWAS assessment on genetic susceptibility to pancreatic cancer
E Lopez de Maturana;J Rodriguez;L Alonso;O Lao;E Molina-Montes;P Gomez-Rubio;R Lawlor;D Albanes;JM Gaziano;P Goodman;M Marti-Renom;F Real;N Malats Genome Medicine Feb 1;13(1):15
PMid: PMID33517887 | PMC number: PMC7849104
F Chen;R Madduri;X Sheng;A Rodriguez;A Chou;B Darst;A Hsing;P Goodman;IM Thompson;EA Klein;J Witte;W Blot;D Conti;JM Gaziano;A Justice;C Haiman American Association for Cancer Research (Week 1: April 10-15; Week 2: May 17-21, 2021 virtual) LBA, oral
Polygenic hazard score is associated with prostate cancer in multi-ethnic populations
M Huynh-Le;C Fan;R Karunamuni;W Thompson;ME Martinez;R Eeles;C Tangen;D Albanes;M-E Parent;J Hu;I Mills;O Andreassen;A Dale;T Seibert Nature Communications Feb 23;12(1):1236
PMid: PMID33623038 | PMC number: PMC7902617
S Julian-Serrano;F Yuan;W Wheeler;B Benyamin;M Machiela;A Arslan;P Goodman;W Zheng;D Albanes;C Fuchs;IM Thompson;B Wolpin;H Risch;L Amundadottir;A Klein;K Yu;R Stolzenberg-Solomon;PanScan PanCfour Consortia American Journal of Clinical Nutrition, Oct 4;114(4):1408-1417
PMid: PMID34258619 | PMC number: PMC8488877
Additional SNPs improve risk stratification of a polygenic hazard score for prostate cancer
R Karunamuni;M Huynh-le;C Fan;W Thompson;R Eeles;Z Kote-Jarai;C Tangen;D Albanes;M Roobol;W Zheng;I Mills;O Andreassen;A Dale;T Seibert Prostate Cancer and Prostatic Diseases, Jun;24(2):532-541
PMid: PMID33420416 | PMC number: PMC8157993
RA Karunamuni;M-P Huynh-Le;CC Fan;W Thompson;A Lui;ME Martinez;BS Rose;B Mahal;RA Eeles;Z Kote-Jarai;K Muir;A Lophatananon;CM Tangen;PJ Goodman;IM Thompson;O Andreassen;AM Dale;TM Seibert Prostate Cancer and Prostatic Diseases Jun 14. doi: 10.1038/s41391-021-00403-7. Online ahead of print
PMid: PMID34127801 | PMC number: PMC8669040
K Tsilidis;N Papadimitriou;N Dimou;D Gill;S Lewis;R Martin;D Albanes;P Goodman;E Platz;J Schenk;S Gruber;U Peters;M Gunter American Journal of Clinical Nutrition Jun 1;113(6):1490-1502. doi: 10.1093/ajcn/nqab003
PMid: PMID33740060 | PMC number: PMC8168352
Adherence with protocol medication use and mortality from unrelated causes in a prevention trial
P Pinsky;P Goodman;H Parnes;L Ford;L Minasian Preventive Medicine Dec;153:106778
PMid: PMID34450188
2020
JM Genkinger;K Wu;M Wang;D Albanes;A Black;P van den Brandt;MB Cook;SM Gapstur;GG Giles;E Giovannucci;G Goodman;P Goodman;N Hakansson;T Key;S Mannisto;L Le Marchand;L Liao;R MacInnis;M Neuhouser;E Platz;N Sawada;J Schenk Kisser;VL Stevens;RC Travis;S Tsugane;K Visvanathan;RL Wilkens;A Wolk;SA Smith-Warner Annals of Oncology Jan;31(1):103-114
PMid: PMID31912782 | PMC number: PMC8195110
A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma among African Americans
Z Du;N Weinhold;C Song;K Rand;D Van Den Berg;A Hwang;X Sheng;V Hom;S Ailawadhi;P Goodman;E Klein;J Zonder;R Orlowski;D Conti;C Haiman;W Cozen Blood Advances Jan 14;4(1):181-190
PMid: PMID31935283 | PMC number: PMC6960456
KC Torkko;C Till;CM Tangen;P Goodman;JM Schenk Kisser;X Song;MS Lucia;A van Bokhoven;U Peters;IM Thompson;ML Neuhouser Cancer Prevention Research Jun;13(6):521-530; Feb 26;canprevres.0413.2019. doi: 10.1158/1940-6207.CAPR-19-0413
PMid: PMID32102946 | PMC number: PMC7272271
M Langston;M Umbehr;J Barber;C Drake;AM De Marzo;P Goodman;B Gurel;SM Lippman;SM Lucia;W Nelson;H Parnes;C Tangen;IM Thompson;EA Platz;S Sutcliffe American Society for Preventative Oncology annual meeting (March 22-24, 2020, Tucson, AZ), poster
M Ahmed;C Goh;E Saunders;C Cieza-Borella;PRACTICAL Consortium;Z Kote-Jarai;F Schumacher;R Eeles Prostate Cancer and Prostatic Diseases Jun;23(2):333-342; Nov 27. doi: 10.1038/s41391-019-0181-y. [Epub ahead of print]
PMid: PMID31776447 | PMC number: PMC7237354
L Hurwitz;I Kulac;B Gumuskaya;J Baena-Del Valle;I Benedetti;F Pan;JO Liu;M Marrone;K Arnold;P Goodman;C Tangen;MS Lucia;IM Thompson;CG Drake;W Isaacs;W Nelson;A De Marzo;EA Platz CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Oct;13(10):853-862; Jun 24;canprevres.0450.2019. doi: 10.1158/1940-6207.CAPR-19-0450. Online ahead of print.
PMid: PMID32581009 | PMC number: PMC7541466
E Vertosick;A Vickers;P Goodman;H Lilja Journal of Urology Vol 203 Issue Suppl 4 April Page: e1092-e1093; (AUA Annual Meeting May 15-18, 2020, Washington DC) #PD52-08, poster
B Darst;P Wan;X Sheng;J Bensen;S Ingles;B Rybicki;B Nemesure;E John;J Fowke;V Stevens;S Berndt;C Huff;S Strom;J Park;W Zheng;E Ostrander;P Walsh;E Yeboah;Y Tettey;R Biritwum;A Adjei;E Tay;S Srivastava;J Carpten;A Truelove;S Niwa;T Sellers;K Yamoah;A Murphy;M Sanderson;D Crawford;S Gapstur;W Bush;M Aldrich;O Cussenot;G Petrovics;J Cullen;C Neslung-Dudas;R Kittles;J Xu;M Stern;Z Jarai;K Govindasami;A Chokkalingam;L Multigner;M Parent;F Menegaux;G Cancel-Tassin;A Kibbel;E Klein;P Goodman;B Drake;J Hu;P Clark;P Blanchet;G Casey;A Hennis;A Lubwama;I Thompson;R Leach;S Gundell;L Pooler;L Xia;J Mohler;E Fontham;G Smith;J Taylor;R Eeles;L Brureau;S Chanock;S Watya;J Stanford;D Mandal;W Isaacs;K Cooney;W Blot;D Conti;C Haiman European Urology Sep;78(3):316-320; May 12;S0302-2838(20)30328-6. doi: 10.1016/j.eururo.2020.04.060. Online ahead of print
PMid: PMID32409115 | PMC number: PMC7805560
S Chadid;X Song;J Schenk;B Gurel;MS Lucia;IM Thompson;M Neuhouser;P Goodman;C Tangen;H Parnes;S Lippman;W Nelson;A De Marzo;E Platz Prostate Aug;80(11):895-905
PMid: PMID32506665 | PMC number: PMC7384586
H Tang;L Jiang;R Stolzenberg-Solomon;A Arslan;L Beane Freeman;P Bracchi;P Goodman;D Albanes;C Fuchs;J Gaziano;I Thompson;H Risch;N Chatterjee;A Klein;D Li;P Kraft;P Wei Cancer Epidemiology Biomarkers & Prevention Sep;29(9):1784-1791; Jun 16;cebp.0275.2020. doi: 10.1158/1055-9965.EPI-20-0275. Online ahead of print.
PMid: PMID32546605 | PMC number: PMC7483330
C Haiman;A Wang;PRACTICAL Consortium American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #1324, poster
Rare germline variants in ATM predispose to prostate cancer: A PRACTICAL Consortium study
Q Karlsson;Z Kote-Jarai;PRACTICAL Consortium American Society of Human Genetics Annual Meeting 2020 (October 27-31, 2020), #2410, poster
Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk
D Ghoneim;J Zhu;W Zheng;J Long;H Murff;F Ye;P Goodman;D Albanes;C Fuchs;JM Gaziano;I Thompson;L Amundadottir;P Kraft;A Klein;R Stolzenberg-Solomon;X-O Shu;L Wu Cancer Epidemiology Biomarkers & Prevention Dec;29(12):2735-2739
PMid: PMID32967863 | PMC number: PMC8195110
A Brandao;P Paulo;S Maia;M Pinheiro;A Peixoto;M Cardoso;C Tangen;D Albanes;M Roobol;Profile Study Steering Cmte;PRACTICAL Consortium;M Teixeira Cancers (Basel) Nov 4;12(11):3254. doi: 10.3390/cancers12113254
PMid: PMID33158149 | PMC number: PMC7694218
2019
N Walsh;H Zhang;P Hyland;Q Yang;E Mocci;M Zhang;G Goodman;P Goodman;D Albanes;C Fuchs;JM Gaziano;EA Klein;AP Klein;L Amundadottir;HA Risch;R Stolzenberg-Solomon Journal of the National Cancer Institute Jun 1;111(6):557-567; Dec 12. doi: 10.1093/jnci/djy155. [Epub ahead of print]
PMid: PMID30541042 | PMC number: PMC6579744
MB Cook;M Barnett;C Bock;A Cross;P Goodman;G Goodman;C Haiman;K-T Khaw;ML McCullough;CC Newton;M-C Boutron-Ruault;E Lund;M Rutegard;M Thornquist;M Spriggs;C Giffen;ND Freedman;T Kemp;CH Kroenke;L Le Marchand;JY Park;M Simon;L Wilkens;L Pinto;A Hildesheim;P Campbell Gut Jun;68(6):960-968; Aug 18. pii: gutjnl-2018-316678. doi: 10.1136/gutjnl-2018-316678. [Epub ahead of print]
PMid: PMID30121626 | PMC number: PMC6379150
Long-term effects of finasteride on prostate cancer mortality [correspondence]
P Goodman;C Tangen;A Darke;MS Lucia;L Ford;L Minasian;H Parnes;M Leblanc;IM Thompson New England Journal of Medicine Jan 24;380(4):393-394
PMid: PMID30673548 | PMC number: n/a - correspondence/letter to editor
J Dai;M Leblanc;P Goodman;MS Lucia;IM Thompson;C Tangen Cancer Prevention Research Feb;12(2):113-120; Dec 11. pii: canprevres.0284.2018. doi: 10.1158/1940-6207.CAPR-18-0284. [Epub ahead of print]
PMid: PMID30538099 | PMC number: PMC6365187
Mechanisms and Funding Opportunities in Genitourinary Cancer Clinical Research [Review]
C Ryan Urologic Oncology: Seminars and Original Investigations, May;37(5):318-323; Jul 31 [Epub ahead of print]
PMid: PMID30072304
Shared heritability and functional enrichment across six solid cancers
X Jiang;H Finucane;F Schumacher;S Schmit;J Tyrer;Y Han;D Albanes;G Goodman;C Tangen;CI Amos;P Craft;S Lindstrom Nature Communications Jan 25;10(1):431
PMid: PMID30683880 | PMC number: PMC6347624
Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study
CD Adams;R Richmond;D Ferreira;D Spiller;V Tan;P Wurtz;C Tangen;D Albanes;H Pandha;SN Thibodeau;RM Martin;PRACTICAL consortium Cancer Epidemiol Biomarkers Prev. Jan;28(1):208-216
PMid: PMID30352818 | PMC number: PMC6746173
R Travis;A Perez-Cornago;PN Appleby;D Albanes;CE Joshu;PL Lutsey;EA Platz;C Tangen;M Deschasaux;T Key;NE Allen Cancer Research Jan 1;79(1):274-285
PMid: PMID30425058 | PMC number: PMC6330070
Extending Randomized Clinical Trial Results through Database Linkages
P Goodman;C Tangen;A Darke;J Unger;C Till;I Thompson Society for Clinical Trials (May 19-22, 2019, New Orleans, LA), oral
IM Thompson;CM Tangen;B Kramer JAMA Internal Medicine Oct 1;179(10):1440
PMid: PMID31589258
More on Long-Term Effects of Finasteride on Prostate Cancer Mortality [reply to letter to editor]
P Goodman;C Tangen;IM Thompson New England Journal of Medicine 2019 May 16;380(20):e38. doi: 10.1056/NEJMc1902700
PMid: PMID31091400
2018
JM Unger;W Barlow;CM Tangen;SD Ramsey;IM Thompson;EA Klein;M LeBlanc;CD Blanke;P Goodman;LM Minasian;DL Hershman Cancer Epidemiology Jun 21;55:117-122
PMid: PMID29936140 | PMC number: PMC6625804
L Tang;M Platek;S Yao;C Till;P Goodman;C Tangen;Y Wu;E Platz;M Neuhouser;F Stanczyk;JK Reichardt;R Santella;A Hsing;W Figg;SM Lippman;IM Thompson;CB Ambrosone Carcinogenesis, Feb 9;39(2):125-133; 2017 Dec 8. [Epub ahead of print]
PMid: PMID29228205 | PMC number: PMC6075364
T Dadaev;E Sanders;P Newcombe;C Tangen;P Goodman;IM Thompson;D Albanes;C Haiman;R Eles;D Conti;Z Kote-Jarai Nature Communications Jun 11;9(1):2256
PMid: PMID29892050 | PMC number: PMC5995836
J Unger;D Hershman;C Till;C Tangen;W Barlow;SD Ramsey;P Goodman;IM Thompson Journal of the National Cancer Institute Nov 1;110(11):1208-1215
PMid: PMID29534197 | PMC number: PMC6235685
Circadian Genes and Risk of Prostate Cancer in the Prostate Cancer Prevention Trial
LW Chu;C Till;B Yang;C Tangen;P Goodman;K Yu;Y Zhu;S Han;A Hoque;C Ambrosone;I Thompson;R Leach;A Hsing Molecular Carcinogenesis Mar;57(3):462-466; Jan 10 [Epub ahead of print]
PMid: PMID29318656 | PMC number: PMC5840353
A Meta-Analysis of Genome-Wide Association Studies of Multiple Myeloma among African Americans
Z Du;K Rand;C Song;P Good;E Klein;J Zonder;R Orlowski;C Haiman;W Cozen American Association for Cancer Research, poster, abst. 223
A Pooled Analysis of Dietary Fiber Intake and Risk of Prostate Cancer
E Sidahmed;SJ Freedland;M Wang;K Wu;J Genkinger;S Smith-Warner American Association for Cancer Research, poster, abst. 5255
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
F Schumacher;AA Al Olama;S Berndt;C Tangen;P Goodman;IM Thompson;D Albanes;C Haiman Nature Genetics Jul;50(7):928-936
PMid: PMID29892016 | PMC number: PMC6568012
JY Dai;M Leblanc;P Goodman;MS Lucia;I Thompson;C Tangen J Clin Oncol 36, 2018 (suppl; abstr 1551); ASCO Annual Meeting (June 1- 5, 2018, Chicago, IL), poster
Reduced Risk of Prostate Cancer With 5a-Reductase Inhibitors. [Editorial]
IM Thompson;P Goodman;C Tangen Journal of the National Cancer Institute Nov 1;110(11):1159-1160; Mar 14. doi: 10.1093/jnci/djy038. [Epub ahead of print]
PMid: PMID29547919 | PMC number: PMCIDPMC6454440
Chemoprevention in Prostate Cancer: Current Perspective and Future Directions [Review]
J Rivero;IM Thompson;M Liss;D Kaushik Cold Spring Harbor Perspectives in Medicine Oct 1;8(10); 2018 Jan 8 [Epub ahead of print]
PMid: PMID29311128 | PMC number: PMC6169981
Low free testosterone and prostate cancer risk: a collaborative analysis of 20 prospective studies
EL Watts;P Appelby;A Perez-Cornago;H Bas Bueno-de-Mesquita;J Chan;C Chen;al et European Urology Nov;74(5):585-594; Aug 1 [Epub ahead of print]
PMid: PMID30077399 | PMC number: PMC6195673
Germline variation at 8q24 and prostate cancer risk in men of European ancestry
M Matejcic;EJ Saunders;T Dadaev;MN Brook;K Wang;X Sheng;A Olama;FR Schumacher;K Govindasami;S Benlloch;S Berndt;D Albanes;S Koutros;K Muir;VL Stevens;SM Gapstur;C Tangen;Z Jarai;DV Conti;CA Haiman Nature Communications Nov 5;9(1):4616
PMid: PMID30397198 | PMC number: PMC6218483
2017
J Petimar;KM Wilson;K Wu;D Albanes;P van den Brandt;MB Cook;GG Giles;GE Goodman;P Goodman;N Haansson;K Helzlsouer;L Kolonel;L Liao;S Mannisto;M McCullough;R Milne;M Neuhouser;Y Park;EA Platz;N Sawada;J Schenk Kisser;S Tsugane;B Verhage;M Wang;Y Wang;L Wilkens;R Ziegler;S Smith-Warner;J Schenk Cancer Epidemiology Biomarkers & Prevention Aug;26(8):1276-1287; Apr 26 [Epub ahead of print]
PMid: PMID28446545 | PMC number: PMC5540798
FL Miles;P Goodman;C Tangen;KC Torkko;J Schenk;X Song;IM Thompson;M Pollak;M Neuhouser Nutrients Apr 12;9(4):378. doi: 10.3390/nu9040378
PMid: PMID28417914 | PMC number: PMC5409717
D Winchester;C Till;P Goodman;C Tangen;R Santella;T Johnson-Pais;R Leach;J Xu;SL Zheng;IM Thompson;MS Lucia;SM Lippman;HL Parnes;WB Isaacs;AM De Marzo;CG Drake;EA Platz Prostate Jun;77(8):908-919
PMid: PMID28317149 | PMC number: PMC5400704
J Unger;W Barlow;C Tangen;S Ramsey;IM Thompson;EA Klein;M Leblanc;C Blanke;P Goodman;L Minasian;D Hershman J Clin Oncol 35, 2017 (suppl; abstr 1541); American Society of Clinical Oncology Annual Meeting (June 2-6, 2017, Chicago, IL), poster session
L Tang;ME Platek;S Yao;C Till;P Goodman;C Tangen;Y Wu;E Platz;ML Neuhouser;F Stanczyk;JK Reichardt;RM Santella;A Hsing;WD Figg;SM Lippman;IM Thompson;CB Ambrosone Proceedings of the American Association for Cancer Research April Vol 58, abst.1274, page 328; AACR Annual Meeting (April 1-5, 2017, Washington, DC), poster
E Platz;I Kulac;J Barber;C Drake;C Joshu;W Nelson;MS Lucia;SM Lippman;HL Parnes;IM Thompson;P Goodman;CM Tangen;A De Marzo CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION Oct;26(10):1549-1557; 2017 Jul 28 [Epub ahead of print]
PMid: PMID28754796 | PMC number: PMC5626618
Z Du;K Rand;C Song;N Weinhold;A Huang;X Sheng;D Van Den Berg;A Nooka;S Ailawadhi;S Singhal;E Peters;K Pawlish;N Janakiraman;H Terebelo;C Bock;A Morbacher;M Tomasson;M Fiala;J Mehta;R Kittles;B Rybicki;JL Stanford;P Goodman;S Berndt;J Carpten;V Horn;A Stram;G Casey;L Chu;W Diver;A Hennis;EM John;E Klein;R Orlowski;D Conti;C Haiman;W Cozen American Society of Hematology, poster, abst. 3058A
Two Novel Susceptibility Loci for Prostate Cancer in Men of African Ancestry
D Conti;K Wang;X Sheng;J Bensen;D Hazelett;MB Cook;A Hsing;P Goodman;IM Thompson;EA Klein;BE Henderson;C Haiman Journal of the National Cancer Institute Aug 1;109(8)
PMid: PMID29117387 | PMC number: PMC5448553
E Watts;P Appleby;D Albanes;A Black;JM Chan;C Chen;P Goodman;JK Parsons;EA Platz;JM Schenk Kisser;IM Thompson;T Key PLoS One Dec 27;12(12):e0187741
PMid: PMID29281666 | PMC number: PMC5744924
2016
D Winchester;B Gurel;C Till;P Goodman;C Tangen;R Santella;T Paris-Johnson;RJ Leach;IM Thompson;J Xu;S Zheng;MS Lucia;SM Lippman;H Parnes;W Isaacs;CD Drake;A De Marzo;E Platz Prostate, May;76(6):565-574
PMid: PMID26771888 | PMC number: PMC4841624
H Chen;X Liu;C Brendler;D Ankerst;RJ Leach;PJ Goodman;MS Lucia;CM Tangen;L Wang;F-C Hsu;J Sun;AK Kader;WB Isaacs;BT Helfand;SL Zheng;IM Thompson;EA Platz;J Xu Prostate Sep;76(12):1120-1129
PMid: PMID27197965 | PMC number: PMC5501387
JM Schenk;C Till;A Hsing;F Stanczyk;Z Gong;M Neuhouser;JK Reichardt;A Hoque;W Figg;P Goodman;CM Tangen;IM Thompson Cancer Causes and Control, Feb;27(2):175-182
PMid: PMID26589415 | PMC number: PMC4724283
D Patel;J Schenk Kisser;A Darke;J Myers;W Brant;J Hotaling British Journal of Urology International, Mar;117(3):500-506
PMid: PMID26269564 | PMC number: PMC4826049
T Murtola;B Gurel;M Umbehr;MS Lucia;IM Thompson;P Goodman;A Kristal;HL Parnes;SM Lippman;S Sutcliffe;S Peskoe;JR Barber;CG Drake;WG Nelson;AM DeMarzo;EA Platz Cancer Epidemiology, Biomarkers & Prevention Mar;25(3):463-469
PMid: PMID26715424 | PMC number: PMC4779655
DK Price;CH Chau;C Till;P Goodman;RJ Leach;TL Johnson-Pais;A Hsing;A Hoque;H Parnes;J Schenk;CM Tangen;IM Thompson;JK Reichardt;WD Figg Cancer Aug 1;122(15):2332-2340; 2016 May 10 [Epub ahead of print]
PMid: PMID27164191 | PMC number: PMC4956504
K Wu;D Spiegelman;Tao Hou;D Albanes;NE Allen;S Berndt;P van den Brandt;G Giles;E Giovannucci;A Goldbohm;G Goodman;P Goodman;N Hakansson;M Inoue;T Key;L Kolonel;S Mannisto;M McCullough;M Neuhouser;AR Kristal;Y Park;E Platz;G Severi;R Sinha;MJ Stampfer;V Stevens;S Tsugane;K Visvanathan;A Wolk;R Ziegler;S Smith-Warner International Journal of Cancer May 15;138(10):2368-2382
PMid: PMID26685908 | PMC number: PMC4837898
D Winchester;C Till;P Goodman;C Tangen;R Santella;R Leach;J Xu;S Zheng;I Thompson;M Lucia;S Lippman;H Parnes;W Isaacs;A De Marzo;C Drake;E Platz American Association for Cancer Research Annual Meeting (April 16 - 20, 2016, New Orleans, LA), abst #812, poster
J Unger;C Till;I Thompson;C Tangen;P Goodman;J Wright;W Barlow;S Ramsey;L Minasian;D Hershman Journal of the National Cancer Institute Aug 26;108(12). pii: djw168. doi: 10.1093/jnci/djw168.
PMid: PMID27565902 | PMC number: PMC5241895
I Kulac;B Gumuskaya;C Drake;B Gonzalez;K Arnold;P Goodman;A Kristal;MS Lucia;IM Thompson;WB Isaacs;AM De Marzo;E Platz Prostate Nov;76(15):1399-1408; 2016 Jun 21 [Epub ahead of print]
PMid: PMID27325488 | PMC number: PMC5497457
C Tangen;P Goodman;C Till;J Schenk Kisser;MS Lucia;IM Thompson Journal of Clinical Oncology Dec 20;34(36):4338-4344. Epub 2016 Oct 28
PMid: PMID27998216 | PMC number: PMC5455311
R Travis;P Appleby;RM Martin;JMP Holly;D Albanes;A Black;HB Bueno-de-Mesquita;JM Chan;C Chen;MD Chirlaque;MB Cook;M Deschasaux;JL Donovan;L Ferrucci;P Galan;G Giles;E Giovannucci;M Gunter;LA Habel;FC Hamdy;K Helzlsouer;S Hercberg;RN Hoover;J Janssen;R Kaaks;T Kubo;T Kubo;L Le Marchand;EJ Metter;K Mikami;JK Morris;D Neal;M Neuhouser;K Ozasa;D Palli;M Pollak;E Platz;AJ Price;MJ Roobol;C Schaefer;J Schenk;G Severi;M Stampfer;P Stattin;A Tamakoshi;C Tangen;M Touvier;NJ Wald;N Weiss;R Ziegler;TJ Key;NE Allen Cancer Research Apr 15;76(8):2288-2300; 2016 Feb 26 [Epub ahead of print]
PMid: PMID26921328 | PMC number: PMC4873385
A Genetic Contribution to Prostate Cancer Incidence in Men of African Ancestry
CA Haiman;DV Conti;ELLIPSE GAME-ON Consortium American Society of Human Genetics Meeting (Oct 18-22, 2016, Vancouver, BC), poster presentation
Evolving recommendations on prostate cancer screening [Review]
OW Brawley;IM Thompson;H Gronberg American Society for Clinical Oncology Educational Book 35:e80-7
PMid: PMID27249774
NE Allen;RC Travis;PN Appleby;D Albanes;MJ Barnett;A Black;H Bueno-de-Mesquita;M Deschasaux;P Galan;G Goodman;P Goodman;M Gunter;M Heliovaara;J Helzlsouer;BE Henderson;S Hercberg;P Knekt;LN Kolonel;C Lasheras;J Linseisen;EJ Metter;M Neuhouser;A Olsen;V Pala;EA Platz;H Rissanen;ME Reid;M Schenk;M Stampfer;P Stattin;C Tangen;M Touvier;A Trichopoulou;P van den Brandt;TJ Key Journal of the National Cancer Institute Jul 6;108(11)
PMid: PMID27385803 | PMC number: PMC5241899
A pooled analysis of glycemic index and load and prostate cancer risk
E Sidahmed;SJ Freedland;M Wang;K Wu;JM Genkinger;SA Smith-Warner American Institute for Cancer Research (Nov 14-16, Bethesda, MD), poster
2015
A Hoque;S Yao;C Till;AR Kristal;P Goodman;AW Hsing;CM Tangen;EA Platz;FZ Stanczyk;JK Reichardt;A vanBokhoven;ML Neuhouser;R Santella;WD Figg;DK Price;HL Parnes;SM Lippman;C Ambrosone;IM Thompson Urology Mar;85(3):616-620
PMid: PMID25733274 | PMC number: PMC4348556
S Sutcliffe;C Till;FJ Jenkins;C Gaydos;P Goodman;A Hoque;A Hsing;IM Thompson;WG Nelson;A De Marzo;E Platz Cancer Causes and Control 26(1):35-44
PMid: PMID25359302 | PMC number: PMC4282945
CH Chau;DK Price;C Till;P Goodman;X Chen;RJ Leach;TL Johnson-Pais;A Hsing;A Hoque;C Tangen;L Chu;H Parnes;JM Schenk;JK Reichardt;IM Thompson;WD Figg PLOS ONE 2015 May 8;10(5):e0126672
PMid: PMID25955319 | PMC number: PMC4425512
MH Umbehr;B Gurel;B Murtola;S Sutcliffe;SB Peskoe;C Tangen;P Goodman;IM Thompson;SM Lippman;MS Lucia;HL Parnes;CG Drake;WG Nelson;AM De Marzo;EA Platz Prostate Cancer and Prostatic Diseases, Sep;18(3):264-269
PMid: PMID25939516 | PMC number: PMC4537352
S Nash;C Till;X Song;EA Platz;JM Schenk Experimental Biology 2015 Conference (March 28-April 1, 2015, Boston, MA), oral presentation, abst. #406.2;
S Nash;J Schenk;A Kristal;P Goodman;MS Lucia;MS Lucia;H Parnes;IM Thompson;SM Lippman;B Gurel;A Demarzo;EA Platz Cancer Prevention Research Jul;8(7):590-596
PMid: PMID25926387 | PMC number: PMC4491033
D Winchester;C Till;P Goodman;C Tangen;R Santella;RJ Leach;J Xu;S Zheng;IM Thompson;MS Lucia;SM Lippman;H Parnes;PJ Dluzniewski;WB Isaacs;AM De Marzo;CG Drake;EA Platz Prostate, Sep;75(13):1403-1418
PMid: PMID26047319 | PMC number: PMC4536102
D Winchester;C Till;P Goodman;C Tangen;R Santella;RJ Leach;J Xu;S Zheng;IM Thompson;M Lucia;S Lippman;H Parnes;PJ Dluzniewski;W Isaacs;AM De Marzo;CG Drake;EA Platz AACR 2015 Meeting (April 18-22, 2015, Philadelphia, PA), abst. 4605, poster presentation;
CM Heaphy;G Gaonkar;S Peskoe;CE Joshu;AM De Marzo;MS Lucia;P Goodman;SM Lippman;IM Thompson;EA Platz;AK Meeker Prostate, Aug;75(11):1160-1166 2015
PMid: PMID25893825 | PMC number: PMC4475463
T Murtola;B Gurel;M Umbehr;MS Lucia;IM Thompson;P Goodman;A Kristal;H Parnes;SM Lippman;S Sutcliffe;S Peskoe;C Drake;W Nelson;A De Marzo;EA Platz American Urological Association Annual Meeting (May 15-19, 2015, New Orleans, LA), poster, abstract #MP4-02
L Minasian;C Tangen;DL Wickerham Seminars in Oncology, Oct;42(5):748-763
PMid: PMID26433556 | PMC number: PMC4593316
S Nash;C Till;X Song;MS Lucia;H Parnes;IM Thompson;S Lippman;EA Platz;JM Schenk Cancer Epidemiology, Biomarkers & Prevention, Oct;24(10):1507-1515
PMid: PMID26269564 | PMC number: PMC4592455
Effect of 5a-reductase inhibitor use on mortality from prostate cancer [Editorial/Commentary]
W Figg;I Thompson JAMA Oncology, Jun;1(3):321-322
PMid: PMID26181178 | PMC number: PMC n/a
Carotenoids, retinol, tocopherols, and prostate cancer risk: pooled analysis of 15 studies
T Key;P Appelby;R Travis;D Albanes;A Alberg;A Barricarte;A Black;H Boeing;H Bas Bueno-de-Mesquita;J Chan;C Chen;MB Cook;JL Donovan;P Galan;R Gilbert;G Giles;E Giovannucci;G Goodman;P Goodman;MJ Gunter;FC Hamdy;M Heliovaara;KJ Helzlsouer;BE Henderson;S Hercberg;J Hoffman-Bolton;RN Hoover;M Johansson;K-T Khaw;IB King;P Knekt;LN Kolonel;L Le Marchand;S Mannisto;RM Martin;HE Meyer;AM Mondul;KA Moy;DE Neal;M Neuhouser;D Palli;EA Platz;C Pouchieu;H Rissanen;JM Schenk;G Severi;MJ Stempfer;A Tjonneland;M Touvier;A Trichopoulou;SJ Weinstein;R Ziegler;C Zhou;NE Allen American Journal of Clinical Nutrition, Nov;102(5):1142-1157
PMid: PMID26447150 | PMC number: PMC4625592
2014
ER Gritz;K Arnold;CM Moinpour;A Burton-Chase;C Tangen;J Probstfield;W See;M Lieber;V Caggiano;S Moody-Thomas;C Szczepanek;A Ryan;S Carlin;S Hill;P Goodman;RM Padberg;L Minasian;F Meyskens;IM Thompson Cancer Epidemiology, Biomarkers & Prevention 23(8):1638-1648;
PMid: PMID25028457 | PMC number: PMC4119542
Enhancing nurse contributions to SWOG clinical trials
L Hansen;C Moinpour;R Ermete Seminars in Nursing Oncology 30(1):26-31;
PMid: PMID24559777 | PMC number: PMC3961058
B Gurel;MS Lucia;IM Thompson;P Goodman;C Tangen;A Kristal;H Parnes;SM Lippman;S Sutcliffe;S Pescoe;C Drake;W Nelson;A DeMarzo;E Platz Cancer Epidemiology, Biomarkers & Prevention 23(5):847-856;
PMid: PMID24748218 | PMC number: PMC4012292
JM Schenk;C Till;CM Tangen;P Goodman;X Song;KC Torkko;AR Kristal;U Peters;M Neuhouser Cancer Epidemiology, Biomarkers & Prevention 23(8):1484-1493;
PMid: PMID25085836 | PMC number: PMC4120235
H Chen;J Sun;D Ankerst;C Tangen;WB Isaacs;SL Zheng;P Goodman;IM Thompson;E Platz;J Xu American Urological Association Annual Meeting (May 16-21, 2014 Orlando, FL), abst. MP69-12; moderated poster session;
Statin drug use is not associated with prostate cancer risk in men who are regularly screened
E Platz;C Tangen;P Goodman;C Till;H Parnes;W Figg;D Albanes;M Neuhouser;E Klein;MS Lucia;IM Thompson;AR Kristal Journal of Urology 192(2):379-384;
PMid: PMID24518774 | PMC number: PMC4104140
Prostate Cancer Prevention Trial: Access to a biorepository and the associated clinical data
P Goodman;C Tangen;MS Lucia;IM Thompson American Society of Preventive Oncology Annual Meeting, poster;
D Ankerst;J Hoefler;S Bock;P Goodman;A Vickers;J Hernandez;LJ Sokoll;M Sanda;J Wei;R Leach;IM Thompson Urology 83(6):1362-1368;
PMid: PMID24862395 | PMC number: PMC4035700
FL Crowe;P Appleby;R Travis;M Barnett;T Brasky;H Bueno-de-Mesquita;J Chavarro;D English;R Gibson;G Giles;G Goodman;S Henning;R Kaaks;I King;L Kolonel;A Kristal;M Neuhouser;SY Park;G Severi;A Siddiq;D Stampfer;P Stattin;C Tangen;A Tionneland;D Trichopoulos;R Tumino;L Wilkens;T Key Journal of the National Cancer Institute Sep 10;106(9): pii: dju240. Print 2014 Sep.;
PMid: PMID2521020 | PMC number: PMC4188122
Health-related quality of life outcomes in prostate cancer prevention clinical trials
C Moinpour International Society for Quality of Life Research annual meeting (Berlin, Germany, Oct. 15-18, 2014); oral presentation;
W Figg;C Chau;D Price;C Till;P Goodman;Y Cho;M Varella-Garcia;JK Reichardt;C Tangen;R Leach;A van Bokhoven;A Kristal;IM Thompson;MS Lucia Urology 84(1):127-131;
PMid: PMID24824408 | PMC number: PMC4077907
Re: Long-term survival of participants in the Prostate Cancer Prevention Trial
IM Thompson;C Tangen;P Goodman Asian Journal of Andrology May-Jun;16(3):414
PMid: PMID24914438 | PMC number: PMC4023368
2013
Projecting prostate mortality in the PCPT and REDUCE chemoprevention trials
PF Pinsky;A Black;R Grubb;ED Crawford;G Andriole;IM Thompson;H Parnes Cancer 119(3):593-601;
PMid: PMID22893105 | PMC number: PMC3502695
Long-term survival of subjects in the Prostate Cancer Prevention Trial (PCPT)
P Goodman;I Thompson;C Tangen;P Godley;L Ford Journal of Clinical Oncology 31 (suppl 6; abstr 10); ASCO Genitourinary Cancers Symposium 2013 (Feb 14-16, 2013, Orlando, Fl), poster;
Long term survival of participants in the Prostate Cancer Prevention Trial
IM Thompson;P Goodman;C Tangen;H Parnes;L Minasian;PA Godley;MS Lucia;L Ford New England Journal of Medicine 369(7):603-610;
PMid: PMID23944298 | PMC number: PMC4141537
M Neuhouser;EA Platz;C Till;C Tangen;P Goodman;A Kristal;H Parnes;Y Tao;WD Figg;MS Lucia;A Hoque;AW Hsing;IM Thompson;M Pollak Cancer Prevention Research 6(2):91-99;
PMid: PMID23315596 | PMC number: PMC3565024
J Schenk;R Hunter-Merrill;Y Zheng;R Etzioni;R Gulati;C Tangen;IM Thompson;A Kristal American Journal of Epidemiology 178(5):741-751;
PMid: PMID23813705 | PMC number: PMC3755644
D Ankerst;C Till;A Boeck;P Goodman;C Tangen;I Thompson Urology Nov;82(5):1076-81
PMid: PMID24055241 | PMC number: PMC3874369
AJ Vickers;DD Sjoberg;DP Ankerst;CM Tangen;P Goodman;IM Thompson Cancer 119(16):3007-3011
PMid: PMID23720006 | PMC number: PMC3735626
Prostate cancer prevention: strategies for agent development [Review]
H Parnes;MG House;JA Tanagrea Current Opinion in Oncology 25(3):242-251
PMid: PMID23518594 | PMC number: n/a - review article
Survival in the prostate cancer prevention trial
C Tangen;P Goodman;IM Thompson New England Journal of Medicine 369(20):1968
PMid: PMID24224632 | PMC number: PMC4927191
D Ankerst;C Till;A Boeck;P Goodman;C Tangen;Z Feng;A Partin;D Chan;L Sokoll;J Kagan;J Wei;IM Thompson Journal of Urology 2013 Jul;190(1):70-76
PMid: PMID23313212 | PMC number: PMC3708069
2012
Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia
JK Parsons;JM Schenk;KB Arnold;K Messer;K Messer;C Till;IM Thompson;A Kristal European Urology, 61(6):1263-1270;
PMid: PMID22459892 | PMC number: PMC4059403
Health-related quality of life findings for the Prostate Cancer Prevention Trial
CM Moinpour;A Darke;G Donaldson;D Cespedes;J Smith;C Johnson;P Ganz;D Patrick;JE Ware;SA Shumaker;FL Meyskens;IM Thompson Journal of the National Cancer Institute 104(18):1373-1385;
PMid: PMID22972968 | PMC number: PMC3529595
AJ Vickers;DP Ankerst;CM Tangen;P Goodman;IM Thompson Journal of Urology 187, No. 4S, Supplement, e492, #1217; American Urological Association Annual Meeting, oral presentation;
S Sutcliffe;C Till;CA Gaydos;FJ Jenkins;P Goodman;A Hoque;AW Hsing;IM Thompson;JM Zenilman;WG Nelson;AM DeMarzo;EA Platz Cancer Causes and Control 23(9):1511-1518;
PMid: PMID25359302 | PMC number: PMC4282945
A Kristal;C Till;C Tangen;PJ Goodman;M Neuhouser;F Stanczyk;LW Chu;SK Patel;WD Figg;A van Bokhoven;SM Lippman;A Hsing Cancer Epidemiology Biomarkers and Prevention 21(10):1823-1832
PMid: PMID22879203 | PMC number: PMC3467348
JM Schenk;GS Calip;C Tangen;P Goodman;JK Parsons;IM Thompson;AR Kristal American Journal of Epidemiology 175(2):
PMid: PMID22759721 | PMC number: PMC3493197
2011
Serum estrogen levels and prostate cancer risk in the Prostate Cancer Prevention Trial: a nested case-control study. PMID 21667068; PMC3139891
S Yao;C Till;A Kristal;P Goodman;A Hsing;C Tangen;E Platz;F Stanczyk;J Reichardt;L Tang;M Neuhouser;R Santella;W Figg;D Price;H Parnes;SM Lippman;IM Thompson;C Ambrosone;A Hoque Cancer Cause and Control 22(8):1121-1131;
Serum phospholipid fatty acids and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21518693; PMC3145396
TM Brasky;E White;M Neuhouser;IM Thompson;X Song;C Till;A Kristal American Journal of Epidemiology 173(12):1429-1439;
Serum lycopene concentration and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID21335507; PMC3070045
A Kristal;C Till;E Platz;X Song;I King;M Neuhouser;C Ambrosone;IM Thompson Cancer Epidemiology Biomarkers Prevention 20(4):638-646
Finasteride reduces the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
JK Parsons;J Schenk;K Arnold;K Messer;C Till;IM Thompson;A Kristal AUA Annual Meeting, accepted, oral, late-breaking
Association of symptomatic benign prostatic hyperplasia and prostate cancer: results from the Prostate Cancer Prevention Trial. PMID21540324
JM Schenk;AR Kristal;KB Arnold;C Tangen;M Neuhouser;DW Lin;E White;IM Thompson American Journal of Epidemiology 173(12):1419-1428
Repeat polymorphisms in estrogen metabolism genes and prostate cancer risk: results from the Prostate Cancer Prevention Trial PMID21771722; PMC3179424
L Tang;S Yao;C Tangen;Y Wu;A Kristal;E Platz;M Neuhouser;F Stanczyk;J Reichardt;R Santella;A Hsing;A Hoque;S Lippman;IM Thompson;C Ambrosone Carcinogenesis 32(10):1500-1506
An empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection
AJ Vickers;C Till;H Lilja;IM Thompson Journal of the National Cancer Institute 103(6):462-469
Re: an empirical evaluation of guidelines on prostate-specific antigen velocity in prostate cancer detection [Commentary]
AJ Vickers Journal of the Nationadld Cancer Institute 103(21):1635-1636
2010
Transition of a clinical trial into translational research: the Prostate Cancer Prevention Trial experience. PMID21149329; PMC3058741
P Goodman;CM Tangen;A Kristal;IM Thompson;MS Lucia;EA Platz;WD Figg;A Hoque;A Hsing;M Neuhouser;H Parnes;J Richardt;R Santella;C Till;SM Lippman Cancer Prevention Research 3(12):1523-1533;
Single nucleotide differences (SNDs) in the dbSNP database may lead to errors in genotyping and haplotyping studies. PMC2797835; PMID:19877174
L Musumeci;J Arthur;F Cheung;A Hoque;S Lippman;J Reichardt Human Mutation 31(1):67-73
Human papillomavirus types 16, 18 and 31 serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial. PMC2820385; PMID: 20142255
S Sutcliffe;R Viscidi;C Till;P Goodman;A Hoque;A Hsing;IM Thompson;J Zenilman;A De Marzo;EA Platz Cancer Epidemiology Biomarkers and Prevention 19(2):614-618
Transparency and reproducibility in data analysis: The Prostate Cancer Prevention Trial. PMC2883301 PMID:20173101
S Baker;A Darke;P Pinsky;H Parnes;B Kramer Biostatistics 11(3):413-418
Androgen receptor CAG repeat length is not associated with the risk of incident symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. PMID:19938041
A Kristal;DK Price;JM Schenk;M Neuhouser;S Ockers;DW Lin;WD Figg Prostate 70(6):584-590
Intra-individual variation in serum C-reactive protein over 4 years: an implication for epidemiologic studies. PMID: 20135215
E Platz;S Sutcliffe;AM De Marzo;CG Drake;N Rifai;A Hsing;A Hoque;M Neuhouser;P Goodman;A Kristal Cancer Causes and Control 21(6):847-851
Biomarkers of systemic inflammation and risk of incident, symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial. PMC2842217;PMID:20142396
JM Schenk;AR Kristal;M Neuhouser;C Tangen;E White;DW Lin;M Kratz;IM Thompson American Journal of Epidemiology 171(5):571-582
Finasteride modifies the relation between serum c-peptide and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID:20179296
M Neuhouser;C Till;A Kristal;P Goodman;A Hoque;E Platz;A Hsing;D Albanes;H Parnes;M Pollak Cancer Prevention Research 3(3):279-289
Serum oxidized protein and prostate cancer risk within the Prostate Cancer Prevention Trial. PMID 20332306; PMC2853720
A Hoque;C Ambrosone;P Goodman;C Tangen;A Kristal;MS Lucia;Q Wang;M Kappil;I Thompson;A Hsing;H Parnes;RM Santella Cancer Prevention Research 3(4):478-483
Diet, supplement use, and prostate cancer risk: results from the Prostate Cancer Prevention Trial. PMID20693267;PMC2950820
A Kristal;K Arnold;ML Neuhouser;P Goodman;D Albanes;IM Thompson American Journal of Epidemiology 172(5):566-577
Editorial Comment
IM Thompson Urology 75(3):509-510
Androgen receptor CAG repeat length and association with prostate cancer risk: results from the prostate cancer prevention trial PMID20952028
DK Price;CH Chau;C Till;P Goodman;CE Baum;SB Ockers;BC English;L Minasian;H Parnes;A Hsing;JK Reichardt;CM Tangen;A Kristal;IM Thompson;WD Figg Journal of Urology 184(6):2297-2302
Prostate-specific antigen, risk factors, and prostate cancer: confounders nestled in an enigma PMID20724727; PMC2935478
IM Thompson;DP Ankerst;CM Tangen Journal of the National Cancer Institute 102(17):1299-1301
2009
Prostate-specific antigen and its role on the Prostate Cancer Prevention Trial
CM Tangen;PJ Goodman Prostate Cancer Screening, 2nd edition, D. Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 24, pp. 333-348
Development of the Prostate Cancer Prevention Trial Prostate Cancer Risk Calculator
DP Ankerst;IM Thompson Prostate Cancer Screening, 2nd edition, DP Ankerst, IM Thompson, C Tangen, Eds., Humana Press, New York, Ch. 12, pp. 195-203.
The performance characteristics of prostate-specific antigen for prostate cancer screening
IM Thompson;DP Ankerst Prostate Cancer Screening, 2nd editiion, DP Ankerst, IM Thompson, C Tangen, eds., Humana Press, New York, Ch. 6, pp. 61-70
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial. PMC2682694;PMID: 19117055.
S Sutcliffe;JF Alderete;C Till;P Goodman;A Hsing;JL Zenilman;AM Demarzo;EA Platz International Journal of Cancer 124(9)2082-2087
Serum adiponectin, c-peptide and leptin and risk of symptomatic beign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
JM Shenk;AR Kristal;ML Neuhouser;CM Tangen;E White;DW Lin Prostate 69(12):1303-1311
Alcohol consumption, finasteride, and prostate cancer risk: results from the Prostate Cancer Prevention Trial
Z Gong;AR Kristal;JM Schenk;CM Tangen;P Goodman;IM Thompson Cancer 1154(16):3661-3669
The performance of PSA for predicting prostate cancer after a prior negative prostate biopsy
CM Tangen Prostate Cancer Screening, 2nd edition, D Ankerst, IM Thompson, C Tangen, eds., Human Press, New York, NY, ch 7, pp 71-78
Men with low serum cholesterol have a lower risk of high-grade prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial (Southwest Oncology Group Study S9217). PMC2877916;PMID:19887582
E Platz;C Till;P Goodman;H Parnes;WD Figg;D Albanes;ML Neuhouser;AR Kristal;EA Klein;IM Thompson Cancer Epidemiology, Biomarkers and Prevention 18(11):2807-2813
Cancer prevention clinical trials: assessing for disparities in recruitment in Hawaii
E Bantum;I Cheng;K Cassel;L Kaopua;J Berenberg Frontiers in Cancer Prevention Research, AACR, abstract #B26, p. 116 (poster presentation)
Chemoprevention of prostate cancer. PMID: 19524966
IM Thompson;CM Tangen;P Goodman;MS Lucia;E Klein Journal of Urology 182(2):499-507
2008
AR Kristal;KB Arnold;JM Schenk;ML Neuhouser;P Goodman;DF Penson;IM Thompson American Journal of Epidemiology 167(8):925-934
PMid: PMID1823602
Does the level of prostate cancer risk affect cancer prevention with finasteride?
IM Thompson;CM Tangen;HL Parnes;SM Lippman;CA Coltman Jr Urology 71(5):854-857
PMid: PMID18455628 | PMC number: PMC2692669
Y Song;C Tangen;P Goodman;HL Parnes;MS Lucia;IM Thompson;AR Kristal The Prostate 68:281-286
PMid: PMID18163420
A Hoque;P Goodman;CB Ambrosone;D Albanes;WD Figg;D Price;W Koop;X Wu;J Conroy;J Reichardt;C Tangen;MS Lucia;T Lehman;RM Santella Urology 71(5):967-970
PMid: PMID18267333 | PMC number: PMC2387066
The performance of prostate specific antigen for predicting prostate cancer is maintained after a prior negative prostate biopsy
IM Thompson;CM Tangen;DP Ankerst;C Chi;MS Lucia;P Goodman;HL Parnes;CA Coltman Journal of Urology 180(2):544-547
PMid: PMID18550097 | PMC number: https://www.ncbi.nlm.nih.gov/pubmed/18550097
Serum steroid and sex hormone binding globulin concentrations and the risk of incident benign prostatic hyperplasia (BPH): Results from the Prostate Cancer Prevention Trial. PMC2387066; PMID: 18267333.
AR Kristal;YJ Song;JM Schenk;KB Arnold;Z Gong;ML Neuhouser;P Goodman;C Tangen;DW Lin;F Stanczyk;IM Thompson American Journal of Epidemiology 168(12):1416-1424
ML Neuhouser;J Schenk;Y Song;CM Tangen;P Goodman;M Pollak;DF Penson;IM Thompson;AR Kristal Prostate 68(13):1477-1486
PMid: PMID18618736 | PMC number: PMC2564287
Integrating the predictiveness of a marker with its performance as a classifier
MS Pepe;Z Feng;Y Huang;G Longton;R Prentice;IM Thompson;Y Zheng American Journal of Epidemiology 167(3):362-368
PMid: PMID179821157 | PMC number: PMC2939738
Does finasteride affect the severity of prostate cancer? A causal sensitivity analysis
BE Shepherd;M Redman;DP Ankerst Journal of the American Statistical Association 103(484):1392-1404
PMid: PMID20526381 | PMC number: PMC2880822
The Prostate Cancer Prevention Trial and the future of chemoprevention. PMID: 18353157
IM Thompson;CM Tangen;MS Lucia British Journal of Urology International 101(8):933-934
MS Lucia;A Darke;P Goodman;FG La Rosa;HL Parnes;LG Ford;CA Coltman;IM Thompson Cancer Prevention Research 1(3):167-173
PMid: PMID19138952 | PMC number: NIHMSID551895
M Redman;C Tangen;P Goodman;MS Lucia;CA Coltman;IM Thompson Cancer Prevention Research 1(3):174-181
PMid: PMID: 19138953 | PMC number: PMC2844801
The Southwest Oncology Group: progress in cancer research [PMID18929152]
CA Coltman Seminars in Oncology 35(5):545-552
JA Sarvis;IM Thompson Current Oncology Reports 10(6):529-532
PMid: PMID: 18928669
EM Grainger;HS Kim;JP Monk;SA Lemeshow;M Gong;RR Bahnson;SK Clinton Urologic Oncology 26(2):125-132
PMid: PMID18312929
Predicting prostate cancer risk through incorporation of prostate cancer gene 3
DP Ankerst;J Groskopf;JR Day;A Blase;H Rittenhouse;BH Pollack;C Tangen;D Parekh;RJ Leach;IM Thompson Journal of Urology 180(4):1303-1308
PMid: PMID18707724
2007
Longitudinal analysis of sexual function reported by men in the prostate cancer prevention trial
CM Moinpour;AK Darke;GW Donaldson;IM Thompson Jr;C Langley;DP Ankerst;DL Patrick;JE Ware Jr;PA Ganz;SA Shumaker;SM Lippman;CA Coltman Jr Journal of the National Cancer Institute 99:1025-1035
Finasteride and high-grade prostate cancer in the Prostate Cancer Prevention Trial
MS Lucia;JI Epstein;PJ Goodman;AK Darke;VE Reuter;F Civantos;CM Tangen;HL Parnes;SM Lippman;F La Rosa;MW Kattan;ED Crawford;LG Ford;CA Coltman Jr;IM Thompson Journal of the National Cancer Institute 99:1375-1383
Finasteride improves the sensitivity of digital rectal examination for prostate cancer detection
IM Thompson;CM Tangen;PJ Goodman;MS Lucia;HLParnes;SM Lippman;CA Coltman, Jr Journal of Urology 177:1749-1752
Finasteride decreases the risk of prostatic intraepithelial neoplasia
IM Thompson;MS Lucia;MW Redman;A Darke;FG La Rosa;HL Parnes;SM Lippman;CA Coltman Journal of Urology 178:107-110
Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the Prostate Cancer Prevention Trial
AR Kristal;KB Arnold;JM Schenk;ML Neuhouser;N Weiss;P Goodman;GM Antvelink;DF Penson;IM Thompson Journal of Urology 177:1395-1400
Prediction of prostate cancer for patients receiving finasteride: results from the Prostate Cancer Prevention Trial
IM Thompson;DP Ankerst;C Chi;PJ Goodman;CM Tangen;SM Lippman;MS Lucia;HL Parnes;CA Coltman, Jr. Journal of Clinical Oncology 25(21):3076-3081
Is prostate-specific antigen velocity useful in early detection of prostate cancer? A critical appraisal of the evidence
RD Etzioni;DP Ankerst;NS Weiss;LY Inoue;IM Thompson Journal of the National Cancer Institute 99(20):1510-1515
Looking back at PCPT: looking forward to new paradigms in prostate cancer screening and prevention
E Canby-Hagino;J Hernandez;TC Brand;IM Thompson European Urology 51(1):27-33
Prostate-specific antigen in the early detection of prostate cancer
IM Thompson;D Ankerst Canadian Medical Association Journal 176(13):1853-1858
2006
The prostate cancer prevention trial: design, biases, and interpretation of study results
PJ Goodman;IM Thompson Jr;CM Tangen;JJ Crowley;LG Ford;CA Coltman Jr Journal of Urology 175:2234-2242
Association of erectile dysfunction and subsequent cardiovascular disease
IM Thompson Jr;J Probstfield;C Tangen;P Goodman;C Moinpour;CA Coltman Jr Proc of the AUA, Journal of Urology 175(4) Suppl:429 (#1333)
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
IM Thompson;DP Ankerst;C Chi;PJ Goodman;CM Tangen;MS Lucia;Z Feng;HL Parnes;CA Coltman, Jr. Journal of the National Cancer Institute 98(8):529-534
Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase
AR Kristal;C Chi;CM Tangen;PJ Goodman;R Etzioni;IM Thompson Cancer 106(2):320-328
Comparison of the operating characteristics of PSA for prostate cancer detection for finasteride and placebo in the Prostate Cancer Prevention Trial
IM Thompson;C Chi;P Goodman;C Tangen;D Pauler Ankerst;MS Lucia;CA Coltman Proc of the AUA, Journal of Urology 175(4) Suppl:152, (#470)
Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevetion trial
Z Gong;ML Neuhouser;PJ Goodman;D Albanes;C Chi;AW Hsing;SM Lippman;EA Platz;MN Pollak;IM Thompson;AR Kristal Cancer Epidemiol Biomarkers Prev 15(10):1977-1983
Effect of finasteride on the sensitivity of PSA for detecting prostate cancer
IM Thompson;C Chi;DP Ankerst;PJ Goodman;CM Tangen;SM Lippman;MS Lucia;HL Parnes;CA Coltman Journal of the National Cancer Institute 98(16):1128-1133
Modeling the effect of a preventive intervention on the natural history of cancer: application to the prostate cancer prevention trial
P Pinsky;R Etzioni;N Howlader;P Goodman;IM Thompson Int Jrnl of Biostatistics 2(1): Art 12. http://www.bepress.com/ijb/vol2/iss1/12
Sensitivity and specificity of prostate-specific antigen for prostate cancer detection with high rates of biopsy verification
DP Ankerst;IM Thompson Archivio Italiano di Urologia, 78(4):125-129
A working group classification of focal prostate atrophy lesions
AM De Marzo;EA Platz;JI Epstein;AT Billis;TY Chan;L Cheng;M Datta;L Egevad;D Ertoy-Baydar;X Farre;S Fine;KA Iczkowski;M Ittmann;BS Knudsen;M Loda;A Lopez-Beltran;C Magi-Galluzzi;G Mikuz;R Montroni;E Pikarski;G Pizov;MA Rubin;H Samaratunga;T Sebo;IA Sesterhenn;R Shah;S Signoretti;J Simko;G Thomas;P Troncoso;T Tsuzuki;J van Leenders;XJ Yang;M Zhou;WD Figg;A Hoque;MS Lucia American Journal of Surgical Pathology 30(10):1281-1291
PMid: PMID17001160 | PMC number: n/a
2005
Estimated impact of the prostate cancer prevention trial on population mortality
JM Unger;IM Thompson;M LeBlanc;JJ Crowley;PJ Goodman;LG Ford;CA Coltman Jr Cancer 103(7):1375-1380
Pathological assessment of high grade tumors in the Prostate Cancer Prevention Trial (PCPT)
MS Lucia;A Darke;P Goodman;C Tangen;CA Coltman;IM Thompson Journal of Urology 173(4):451 (#1664)
Prostate specific antigen (PSA) as a predictor of adverse pathological features at prostatectomy in the Prostate Cancer Prevention Trial (PCPT)
MS Lucia;P Goodman;C Tangen;CA Coltman;IM Thompson Journal of Urology 173(4):143 (#525)
The performance characteristics of prostate-specific antigen
IM Thompson;DP Ankerst;C Chi;P Goodman;C Tangen;CA Coltman Jr Journal of Urology 173(4):143 (#526)
Operating characteristics of prostate-specific antigen in men with an initial psa level of 3.0 ng/mL or lower
IM Thompson;DP Ankerst;C Chi;MS Lucia;PJ Goodman;JJ Crowley;HL Parnes;CA Coltman The Journal of the American Medical Association 294(1):66-70
Assessing benefit and risk in the prevention of prostate cancer: the prostate cancer prevention trial revisited.
EA Klein;CM Tangen;PJ Goodman;SM Lippman;IM Thompson Journal of Clinical Oncology 23(30):7460-7466
Erectile dysfunction and subsequent cardiovascular disease
IM Thompson;CM Tangen;P Goodman;JL Probstfield;CM Moinpour;CA Coltman JAMA 294(23):2996-3002
Individual prediction of prostate cancer based on prostate specific antigen
C Chi;D Pauler Ankerst;P Goodman Clinical Trials 2 (Suppl 1):P40
Long-term effects of finasteride on prostate specific antigen levels: results from the prostate cancer prevention trial
RD Etzioni;N Howlader;PA Shaw;DP Ankerst;DF Penson;PJ Goodman;IM Thompson Journal of Urology 174:877-881
Phase III prostate cancer prevention trials: are the costs justified?
IM Thompson;CM Tangen;EA Klein;SM Lippman Journal of Clinical Oncology 23(32):8161-8164
2004
Implementation of the prostate cancer prevention trial (PCPT)
PJ Goodman;CM Tangen;JJ Crowley;SM Carlin;A Ryan;CA Coltman, Jr.;LG Ford;IM Thompson Controlled Clinical Trials 2:203-222
Prevalence of prostate cancer among men with a prostate-specific antigen level < 4.0 ng per milliliter
IM Thompson;DK Pauler;PJ Goodman;CM Tangen;MS Lucia;HL Parnes;LM Minasian;LG Ford;SM LIppman;ED Crawford;JJ Crowley;CA Coltman Jr New England Journal of Medicine 350(22):2239-2246
Statistical design issues and other practical considerations for conducting phase III prostate cancer prevention trials
CM Tangen;PJ Goodman;JJ Crowley;IM Thompson Journal of Urology 171:S64-S67
The person-years saved model and other methodologies for assessing the population impact of cancer-prevention strategies
JM Unger;M LeBlanc;IM Thompson;CA Coltman Jr Urologic Oncology: Seminars and Original Investigations 22:362-368
Prostate cancer chemoprevention: an overview of United States trials
A Barqawi;IM Thompson;ED Crawford Journal of Urology 171:S5-S9
First international conference on chemoprevention of prostate cancer
IM Thompson;D Albanes;JW Basler;ED Crawford;LJ Denis;B Djavan;N Fleshner;TL Johnson-Pais;EA Klein;AR Kristal;MS Lucia;HL Parnes;GA Piazza;EA Platz;BH Pollock;DK Price;JK Reichardt;CM Tangen;AW Tolcher;MC McMann Journal of Urology 171:S3-S4
The prostate cancer prevention trial: the association of study site and participant adherence interventions to the study site end-of-study biopsy rates
S Carlin;P Goodman;C Moinpour;C Tangen Clinical Trials 1 (Suppl 1):P45
2003
The prostate cancer prevention trial: design, status, and promise
IM Thompson;C Tangen;P Goodman World Journal of Urology 21:28-30
The influence of finasteride on the development of prostate cancer
IM Thompson;PJ Goodman;CM Tangen;MS Lucia;GJ Miller;LG Ford;MM Lieber;RD Cespedes;JN Atkins;SM Lippman;SM Carlin;A Ryan;CM Szczepanek;JJ Crowley;CA Coltman Jr New England Journal of Medicine 349:215-224
The prostate cancer prevention trial: did the adherence interventions for the end of study biopsy really work?
S Carlin;P Goodman;C Moinpour;S Hill Controlled Clinical Trials 24(3S):P222
2002
Energy from fat is associated with obesity in US men: results from the prostate cancer prevention trial
J Satia-Abouta;RE Patterson;RN Schiller;AR Kristal Preventive Medicine 34:493-501
Biomarker-based methods for determining non-compliance in a prevention trial
K Gower;DK Pauler;PJ Goodman Controlled Clinical Trials 23(2S):49S-50S(#26)
Biomarker-based methods for determining noncompliance in a prevention trial
DK Pauler;KB Gower;PJ Goodman;JJ Crowley;IM Thompson Controlled Clinical Trials 23:675-685
2001
The prostate cancer prevention trial: current status and lessons learned
IM Thompson;M Kouril;EA Klein;CA Coltman;A Ryan;P Goodman Urology 57(Suppl.4A):230-234
Promoting adherence to the prostate cancer prevention trial end of study biopsy requirement
AM Ryan;P Goodman;S Hill;C Moinpour Controlled Clinical Trials 22(2S):88S(#P71)
Dietary supplement use in the prostate cancer prevention trial: implications for prevetion trials.
ML Neuhouser;AR Kristal;RE Patterson;PJ Goodman;IM Thompson Nutrition and Cancer 39(1):12-18
2000
Television and news print media are effective in recruiting potential participants in a prostate cancer chemoprevention trial.
TDK Chung;II Park;L Ignacio;R Catchatourian;MA Kopnick;E Davison;G Conrad;AM Awan;ED Crawford;S Vijayakumar International Journal of Cancer 90:302-304
Profile of men randomized to the prostate cancer prevention trial: Baseline health-related quality of life, urinary and sexual functioning, and health behaviors.
CM Moinpour;L Lovato;IM Thompson;JE Ware;PA Ganz;DL Patrick;SA Shumaker;GW Donaldson;A Ryan;CA Coltman Journal of Clinical Oncology 18(9):1942-1953
Behavioral science research in the cooperative group setting: the Southwest Oncology Group Experience
CC Gotay;CM Moinpour;S Moody-Thomas;ER Gritz;KS Albain;E DeAntoni;L Hansen;PA Ganz Journal of the National Cancer Institute 92(17):1381-1387
Dietary supplement use in the prostate cancer prevention trial: implications for study findings
ML Neuhouser;AR Kristal;RE Patterson;IM Thompson American Society of Prevention Oncology :#76
Letter to the Editor: RE: RE: Chemoprevention of urological cancer
IM Thompson;CA Coltman Journal of Urology 164(4):1321-1322
Minority recruitment in the prostate cancer prevention trial
CM Moinpour;JO Atkinson;SM Thomas;S Millon-Underwood;C Harvey;J Parzuchowski;LC Lovato;AM Ryan;S Hill;E DeAntoni;ER Gritz;IM Thompson, Jr;CA Coltman, Jr Annals of Epidemiology 10(S8):S85-S91
1999
Prostate cancer prevention trial (PCPT) update.
CA Coltman Jr;IM Thompson Jr;P Feigl European Urology 35:544-547
Letters to the Editor: The effect of finasteride on the prostate gland in men with elevated serum prostate-specific antigen level
CA Coltman British Journal of Cancer 81(1):184-185
Validity of short food frequency questionnaires used in cancer chemoprevention trials: results from the prostate cancer prevention trial
ML Neuhouser;AR Kristal;D McLerran;RE Patterson;J Atkinson Cancer Epidemiology Biomarkers & Prevention 8:721-725
1998
Army and Air Force leadership in the prostate cancer prevention trial.
J Allerton;T Seay;S Optenberg;CA Coltman Jr;B Higgins;I Thompson;L Lovato Urology 51(Suppl.4A):64-66
1997
Chemoprevention of prostate cancer: The prostate cancer prevention trial.
IM Thompson;CA Coltman Jr;J Crowley The Prostate 33:217-221
Utility of the enrollment period in the prostate cancer prevention trial (PCPT).
PJ Goodman;L Lovato;A Ryan;J Crowley;C Moinpour;I Thompson Controlled Clinical Trials 18(S3)(#19):52S
Data operations management with clinical datafax: The prostate cancer prevention trial (PCPT) experience.
AM Ryan;L Emel;P Goodman Controlled Clinical Trials 18(S3)(#P74):156S
Clinical Trials: A Congressional Focus of Need.
CA Coltman, Jr. The Oncologist [Guest Editorial] 2(4):vii-viii
PMid: PMID10388059
1996
The prostate cancer prevention trial: Efforts to increase the recruitment of minority participants.
CM Moinpour Poster for Conf on the Recruit and Retention of Min Parts in CCR 1/26-27/96 :
Prostate cancer prevention trial.
BH Zoltick Presented at the AUAA Annual Assembly-Orlando Florida May 4-7 :
Screening for prostate cancer: Opportunities for prevention.
IM Thompson;CA Coltman Jr Seminars in Urologic Oncology 14(2)(Suppl.2):4-11
Chemoprevention of prostate cancer with finasteride.
I Thompson;P Feigl;C Coltman Principles and Practice of Oncology 10(3):1-18
The prostate cancer prevention trial.
A Ryan Prevention/Early Detection SIG Newsletter 6(3):1
1995
Design of the prostate cancer prevention trial (PCPT)
P Feigl;B Blumenstein;I Thompson;J Crowley;M Wolf;BS Kramer;CA Coltman Jr;OW Brawley;LG Ford Controlled Clinical Trials 16:150-163
Chemoprevention of prostate cancer with finasteride
I Thompson;P Feigl;C Coltman Important Advances in Oncology, JB Lippincott Co :57-76
Chemoprevention of prostate cancer with finasteride: An Intergroup trial
CA Coltman Jr;P Feigl;IM Thompson Cancer Investigation 13(Suppl.1):43(#36)
Chemoprevention of prostate cancer.
IM Thompson;CA Coltman;OW Brawley;A Ryan Seminars in Urology 13(2):122-129
1994
Chemoprevention of prostate cancer with finasteride, an Intergroup trial
CA Coltman Jr;J Unger;IM Thompson Annals of Oncology [Corrigendum6(6)621-1995]5(Suppl.8):65(#P324)
Prostate cancer prevention: Risk reduction through life-style, diet, and chemoprevention
KE Greco;L Kulawiak Oncology Nursing Forum 21(9):1504-1511
The prostate cancer prevention trial. A low-risk, high-accrual study.
J O'Connor Oncology Issues 9(5):20-24
1993
Chemoprevention of prostate cancer with finasteride
I Thompson;P Feigl;C Coltman Cancer Prevention Dec:1-15